This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Type B Aortic Dissection
and you are
between 18 and 80
years old
The phase for this study is not defined.
Show me locations

The purpose

The primary objective of this study is to determine the safety and efficacy of the GORE Conformable TAG Thoracic Endoprosthesis (CTAG) for treatment of subjects with acute complicated type B aortic dissection.

Provided treatments

  • Device: GORE TAG® Thoracic Endoprosthesis
Tris trial is registered with FDA with number: NCT00908388. The sponsor of the trial is W.L.Gore & Associates and it is looking for 50 volunteers for the current phase.
Official trial title:
Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for Treatment of Acute Complicated Type B Aortic Dissection